Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease
AffiliationUniv Arizona, Dept Surg, Mel & Enid Zuckerman Coll Publ Hlth
Univ Arizona, Dept Biostat & Epidemiol, Mel & Enid Zuckerman Coll Publ Hlth
MetadataShow full item record
PublisherPIONEER BIOSCIENCE PUBL CO
CitationVij P, Chen D, Hsu CH, Pandit V, Omesiete P, Elquza E, Scott A, Cruz A, Nfonsam V. Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease. J Gastrointest Oncol 2019;10(2):254-258. doi: 10.21037/jgo.2019.01.06
Rights© Journal of Gastrointestinal Oncology. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractBackground: Studies have explored the relationship between inflammatory bowel disease (IBD) [ulcerative colitis (UC) and Crohn's disease (CD)] and colon cancer (CC). Additionally, racial disparities in the incidence of CC is well known. However, the impact of racial disparity in IBD patients who develop CC remains unclear. The aim of this study is to address the knowledge gap in this particular group of patients. Methods: A retrospective analysis was done using the National Inpatient Sample (NIS) database from 2011. We included patients with IBD over age >= 18 years with a diagnosis of CC. Patients were stratified by race, gender, age, presence of IBD and CC. Statistical analysis was performed to compare the groups. Results: A total of 57,542 patients were included (CD: 36,357, UC: 21,001). Of all patients with and without IBD, advanced age, Black and Asian race conferred an increased risk of developing CC, whereas female gender, Hispanic and Native American race conferred a protective effect. In patients with IBD, advanced age conferred an increased risk for developing CC while female gender conferred a protective effect. In this subset of patients, black race conferred a protective effect. Conclusions: Racial disparity exists in the overall incidence of CC and among patients with IBD who develop CC. Interestingly, black race conferred a protective effect for patients with IBD, contrary to what is seen in the general population. These findings could be attributed to the environmental factors and genetic makeup between racial groups. Further studies are warranted to better understand these disparities.
NoteOpen Access Journal
VersionFinal published version
- Racial disparities exist in surgical outcomes for patients with inflammatory bowel disease (IBD).
- Authors: Dos Santos Marques IC, Theiss LM, Wood LN, Gunnells DJ, Hollis RH, Hardiman KM, Cannon JA, Morris MS, Kennedy GD, Chu DI
- Issue date: 2020 Dec 7
- Clinicopathological significance of lymphocytic colitis/collagenous colitis in inflammatory bowel disease.
- Authors: Yuan L, Wu TT, Chandan V, Huang Y, Zhang L
- Issue date: 2020 Feb
- Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States.
- Authors: Malaty HM, Hou JK, Thirumurthi S
- Issue date: 2010
- Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.
- Authors: Ehrenpreis ED, Zhou Y
- Issue date: 2017 Jul 14
- Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia.
- Authors: Mangat BK, Evaschen C, Lee T, Yoshida EM, Salh B
- Issue date: 2011 Feb